一品紅(300723.SZ):李捍東、吳春江提前終止減持計劃 已合計減持2.01%股份
格隆匯9月3日丨一品紅(300723.SZ)公佈,2021年9月2日,公司分別收到董事李捍東、股東吳春江出具的《關於提前結束股份減持的吿知函》和《關於股份減持計劃的吿知函》,李捍東、吳春江披露的減持計劃已提前實施完畢。
截止目前,李捍東累計通過集中競價和大宗交易方式減持公司股份290.7691萬股,佔當前公司總股本的1.01%;吳春江累計通過大宗交易方式減持公司股份288.6538萬股,佔當前公司總股本的1.00%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.